OBJECTIVE: To determine whether ICU-acquired paresis (ICUAP) is an independent risk factor of prolonged weaning. DESIGN: Second study of a prospective cohort of 95 patients who were enrolled in an incidence and risk factor study of ICUAP. SETTING: Three medical and two surgical ICUs in four hospitals. PATIENTS AND PARTICIPANTS: Ninety-five patients without pre-existing neuromuscular disease recovering from the acute phase of critical illness after > or =7 days of mechanical ventilation. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Duration of weaning from mechanical ventilation was defined as the duration of mechanical ventilation between awakening (day 1) and successful weaning. Muscle strength was evaluated at day 7 after awakening using the Medical Research Council (MRC) score. Patients with an MRC <48 were considered to have ICUAP. Among the 95 patients (mean age 62.0+/-15.3 years, SAPS 2 on admission 48.7+/-17.4) who regained satisfactory awakening after 7 or more days of mechanical ventilation, 67 (70.5%) were hospitalized in a medical ICU and 28 (29.5%) in a surgical ICU. Median duration (25th-75th percentiles) of weaning was longer in patients with ICUAP than in those without ICUAP: 6 days (1-22 days) vs 3 days (1-7 days); p=0.01; log-rank analysis. In multivariate analysis, the two independent predictors of prolonged weaning were ICUAP [hazard ratio (HR): 2.4; 95% confidence interval (CI): 1.4-4.2] and chronic obstructive pulmonary disease (HR: 2.7; 95% CI: 1.6-4.5) CONCLUSIONS: ICU-acquired paresis is an independent predictor of prolonged weaning. Prevention of ICU-acquired neuromuscular abnormalities in patients recovering from severe acute illness should result in shorter weaning duration.
OBJECTIVE: To determine whether ICU-acquired paresis (ICUAP) is an independent risk factor of prolonged weaning. DESIGN: Second study of a prospective cohort of 95 patients who were enrolled in an incidence and risk factor study of ICUAP. SETTING: Three medical and two surgical ICUs in four hospitals. PATIENTS AND PARTICIPANTS: Ninety-five patients without pre-existing neuromuscular disease recovering from the acute phase of critical illness after > or =7 days of mechanical ventilation. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Duration of weaning from mechanical ventilation was defined as the duration of mechanical ventilation between awakening (day 1) and successful weaning. Muscle strength was evaluated at day 7 after awakening using the Medical Research Council (MRC) score. Patients with an MRC <48 were considered to have ICUAP. Among the 95 patients (mean age 62.0+/-15.3 years, SAPS 2 on admission 48.7+/-17.4) who regained satisfactory awakening after 7 or more days of mechanical ventilation, 67 (70.5%) were hospitalized in a medical ICU and 28 (29.5%) in a surgical ICU. Median duration (25th-75th percentiles) of weaning was longer in patients with ICUAP than in those without ICUAP: 6 days (1-22 days) vs 3 days (1-7 days); p=0.01; log-rank analysis. In multivariate analysis, the two independent predictors of prolonged weaning were ICUAP [hazard ratio (HR): 2.4; 95% confidence interval (CI): 1.4-4.2] and chronic obstructive pulmonary disease (HR: 2.7; 95% CI: 1.6-4.5) CONCLUSIONS: ICU-acquired paresis is an independent predictor of prolonged weaning. Prevention of ICU-acquired neuromuscular abnormalities in patients recovering from severe acute illness should result in shorter weaning duration.
Authors: M I Polkey; A Duguet; Y Luo; P D Hughes; N Hart; C H Hamnegård; M Green; T Similowski; J Moxham Journal: Intensive Care Med Date: 2000-08 Impact factor: 17.440
Authors: G van den Berghe; P Wouters; F Weekers; C Verwaest; F Bruyninckx; M Schetz; D Vlasselaers; P Ferdinande; P Lauwers; R Bouillon Journal: N Engl J Med Date: 2001-11-08 Impact factor: 91.245
Authors: J Garnacho-Montero; J Madrazo-Osuna; J L García-Garmendia; C Ortiz-Leyba; F J Jiménez-Jiménez; A Barrero-Almodóvar; M C Garnacho-Montero; M R Moyano-Del-Estad Journal: Intensive Care Med Date: 2001-08 Impact factor: 17.440
Authors: Daniel Tuchscherer; Werner J Z'graggen; Christina Passath; Jukka Takala; Christer Sinderby; Lukas Brander Journal: Intensive Care Med Date: 2011-11-03 Impact factor: 17.440
Authors: Sheetal Gandotra; James Lovato; Douglas Case; Rita N Bakhru; Kevin Gibbs; Michael Berry; D Clark Files; Peter E Morris Journal: Ann Am Thorac Soc Date: 2019-04
Authors: Pleuni E Hooijman; Albertus Beishuizen; Christian C Witt; Monique C de Waard; Armand R J Girbes; Angelique M E Spoelstra-de Man; Hans W M Niessen; Emmy Manders; Hieronymus W H van Hees; Charissa E van den Brom; Vera Silderhuis; Michael W Lawlor; Siegfried Labeit; Ger J M Stienen; Koen J Hartemink; Marinus A Paul; Leo M A Heunks; Coen A C Ottenheijm Journal: Am J Respir Crit Care Med Date: 2015-05-15 Impact factor: 21.405
Authors: Boris Jung; Pierre Henri Moury; Martin Mahul; Audrey de Jong; Fabrice Galia; Albert Prades; Pierre Albaladejo; Gerald Chanques; Nicolas Molinari; Samir Jaber Journal: Intensive Care Med Date: 2015-11-16 Impact factor: 17.440
Authors: R Gosselink; J Bott; M Johnson; E Dean; S Nava; M Norrenberg; B Schönhofer; K Stiller; H van de Leur; J L Vincent Journal: Intensive Care Med Date: 2008-02-19 Impact factor: 17.440